Search

everythinglearnresearchcommunity

for

Search:↓

Genetically repaired stem cells may treat certain genetic diseases, Th17 cells are key in fighting systemic fungal infections, hair loss in AGA is due to progenitor cell loss, and α-synuclein transfer might contribute to Parkinson's disease progression.

Some drugs can cause serious side effects like heart issues and nervous system problems, but certain drugs for Parkinson's and overactive bladder may be safer, though they still have some common side effects.

The document concludes that immune system abnormalities cause alopecia areata, but the exact process is still not completely understood.

AI is revolutionizing healthcare by improving diagnosis, treatment, and monitoring, but still needs close supervision.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

Patients in Australia underwent costly, unproven stem cell treatments due to weak regulations and aggressive marketing.

Researchers found two new genetic variants linked to Alzheimer's disease.

Seborrhea in Parkinson's disease may be linked to hormones, not autonomic impairment.

Dopaminergic therapy in Parkinson's disease patients is linked to increased hair loss.

Kennedy's disease leads to muscle weakness and sensory issues, has no cure but manageable symptoms, and future treatments look promising.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Parkinson's disease is linked to skin disorders and skin cells help in studying the disease.

Radiotherapy was effective for treating a large scalp plaque of Bowen's disease when other treatments failed.

The LRRK2-G2019S mutation in Parkinson's disease has a lifetime penetrance of 25-35%, and finasteride may help reduce symptoms in adult male Tourette syndrome patients.

Addressing underrepresentation in Parkinson's research is crucial for better treatments and understanding.

New treatments for skin conditions related to the sebaceous gland are being developed based on current research.

Sodium selenate was found to be safe and possibly slows Alzheimer's progression, but more research is needed.

Targeting NETs may help reduce fibrosis in Crohn's disease.

The interdisciplinary approach improved the quality of life for a Parkinson's patient and eased staff workload.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

The document discusses various eye conditions and their treatments, including a rare eye cancer in a baby, vision loss from a cancer drug, cataracts from a baldness treatment, a rare skin disorder, and a specific type of eye disease diagnosed with a special imaging technique.

Sex and sex hormones can affect brain inflammation in Parkinson's disease, with male mice being more affected and female mice showing a protective effect.

Increasing research diversity is key for better understanding and treating Parkinson's Disease.

International medical graduates outperformed U.S. graduates on an internal medicine exam.

The book "Diseases of the Hair and Scalp" has outdated information and confusing content, but may still offer some insights.

The document concludes that low-dose oral contraceptives and hormonal therapies can manage perimenopause symptoms and reduce some health risks, but lifestyle changes and disease screening are also important.

Pregnenolone might help manage movement issues caused by Parkinson's disease treatment without reducing the medicine's effectiveness.

Certain genetic variants in ERN1, TACR3, and SPPL2C are linked to when Alzheimer's disease starts.

Dr. Conroy's book on Morgellon's disease lacks credible evidence and scientific validity.

Skin problems can indicate different diseases inside the body.